Patterns of antifungal prescribing in general dental practice

British Dental Journal

Volumn 196, Issue 11, 2004, Pages

  Oliver, R J ^a,c   Dhaliwal, H S ^d   Theaker, E D ^b   Pemberton, M N ^c  

^a Oral and Maxillofacial Surgery   (United Kingdom)

^b Oral Medicine

^c UNIVERSITY DENTAL HOSPITAL OF MANCHESTER   (United Kingdom)

^d Univ Dental Hospital of Manchester ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; FLUCONAZOLE; MICONAZOLE; NYSTATIN; PYRROLE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENTISTRY; DRUG CHOICE; DRUG USE; GENERAL PRACTITIONER; HUMAN; POSTAL MAIL; PRESCRIPTION; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; UNITED KINGDOM;

AGE FACTORS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDIASIS, ORAL; DENTIST'S PRACTICE PATTERNS; FLUCONAZOLE; GENERAL PRACTICE, DENTAL; GREAT BRITAIN; HUMANS; MICONAZOLE; NYSTATIN; PRESCRIPTIONS, DRUG; QUESTIONNAIRES;

EID: 3042517113     PISSN: 00070610     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bdj.4811354     Document Type: Article

References (18)

1. Rex J H, Rinaldi M G, Pfaller M A. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995; 39: 1-8.
2. Lewis M A O, Meechan C, Macfarlane T W, Lamey P J, Kay E. Presentation and antimicrobial treatment of acute orofacial infections in general dental practice. Br Dent J 1989; 166: 41-45.
3. British Medical Association and the Royal Pharmaceutical Society of Great Britain. Dental Practitioners' Formulary 2000-2002. London: 2000;
4. British Medical Association and the Royal Pharmaceutical Society of Great Britain. Dental Practitioners' Formulary 1986-1988. London: 1986;
5. Bagg J, MacFaralne T W, Poxton I R, Miller C H, Smith A J. Anonymous essentials of microbiology for dental students. Oxford: Oxford University Press, 1999; 105-116.
6. White T C, Marr K A, Bowden R A. Clinical, cellular and molecular factors that contribute to antifungal resistance. Clin Microbiol Rev 1998; 11: 382-402.
7. Budtz-Jörgensen E, Lombardi T. Antifungal therapy in the oral cavity. Periodontol 2000 1996; 10: 89-106.
8. Bissel V, Felix D H, Wray D. Comparative trial of fluconazole and amphotericin in the treatment of denture stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1993; 76: 35-39.
9. Pemberton M N, Sloan P, Ariyaratnam S, Thakker N S, Thornhill M H. Derangement of warfarin anti-coagulation by miconazole oral gel. Br Dent J 1998; 184: 68-69.
10. Martin M V. The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review. J Antimicrob Chemother 1999; 44: 429-437.
11. Cross L J, Bagg J, Wray D, Aitchison T. A comparison of fluconazole and itraconazole in the management of denture stomatitis: a pilot study. J Dent 1998; 26: 657-664.
12. Haberland-Carrodeguas C, Allen C M, Beck F M, Buesching W J, Koletar S L, Sundstrom P. Prevalence of fluconazole-resistant strains of Candida albicans in otherwise healthy outpatients J Oral Pathol Med 2002; 31: 99-105.
13. Hudson M M T. Antifungal resistance and over-the-counter availability in the UK: a current perspective. J Antimicrob Chemother 2001; 48: 345-350.
14. Meiller T F, Kelley J I, Jabra-Rizk M A, DePaola L G, Baqui A A M A, Falkler W A. In vitro studies of the efficacy of antimicrobials against fungi. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91: 663-670.
15. Ellepola A N B, Samaranayake L P. Adjunctive use of chlorhexidine in oval candidoses: a review. Oral Dis 2001; 7: 11-17.
16. Barkovv P, Attramadal A. Effect of nystatin and chlorhexidine gluconate on C. albicans. Oral Surg Oral Med Oral Pathol 1989; 67: 279-281.
17. Giuliana G, Pizzo G, Milici M E, Giangreco R. In vitro activities of antimicrobial agents against Candida species. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87: 44-49.
18. Hammer K A, Carson C F, Riley T V. In-vitro activity of essential oils, in particular, Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. J Antimicrob Chemother 1998; 42: 591-595.